KMA Holding, Inc. (MCDA) Stock Price & Analysis
Educational signal · not a buy or sell recommendation · How to read this
Market cap $4.24M is the value of all shares combined.
For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 16, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Quick AnswerKMA Holding, Inc. (MCDA) trades at $0.0001. KMA Holding, Inc. manufactures and distributes home medical test kits and emergency response mobile hospital units. Market cap: $4.24M, Sector: Healthcare.
Price as of · Last analyzed: Mar 16, 2026Analyst Coverage for MCDA: MCDA does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage.
No score published: we hold no usable price for this ticker, and a grade beside a missing price says nothing.
KMA Holding, Inc. (MCDA) Healthcare & Pipeline Overview
KMA Holding, Inc. specializes in manufacturing and distributing home medical test kits and emergency response mobile hospital units, focusing on early illness detection. Operating within the medical instruments and supplies sector, the company aims to provide accessible diagnostic tools and mobile medical solutions, primarily in the United States.
What Is the Investment Thesis for MCDA?
KMA Holding, Inc. presents a speculative investment opportunity within the home medical testing and mobile medical solutions market. The company's focus on early disease detection and mobile emergency response units addresses growing healthcare needs. However, with a market capitalization of $4.24M and a beta of -3.02, the company exhibits high risk and volatility. Revenue generation and profitability remain uncertain. Potential investors should carefully consider the company's OTC market listing, limited financial disclosure, and shell risk detection. Growth depends on successful market penetration and regulatory approvals. The investment thesis hinges on KMA's ability to scale production and distribution effectively.
Based on FMP financials and quantitative analysis
MCDA Key Highlights
KMA Holding, Inc. manufactures home medical test kits for humans and pets, focusing on early disease detection.
- The company also provides emergency medical response mobile hospital units, offering temporary life support and medical services.
- KMA Holding operates in the OTC market, which presents unique risks and challenges compared to major exchanges.
- The company's beta of -3.02 indicates an inverse correlation with the market, suggesting potential for diversification but also higher risk.
- KMA Holding, Inc. has no dividend yield, indicating that the company is not currently returning profits to shareholders.
Who Are MCDA's Competitors?
MCDA is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | MoonshotScore |
|---|---|---|---|---|
| BRSYF BrainsWay Ltd. | $12.60 | -16.72% | $506M | — |
| CYBQY CYBERDYNE Inc. | $1.51 | 0.00% | $270M | — |
| GNFTF Genfit S.A. | $15.75 | 0.00% | $789M | — |
| MFCSF Medical Facilities Corporation | $10.41 | -0.57% | $183M | — |
| LUCY Innovative Eyewear, Inc. | $0.89 | -3.14% | $5.62M | — |
| FEMY Femasys Inc. | $2.05 | -2.38% | $6.19M | — |
| RGNT Regentis Biomaterials Ltd. | $1.85 | +1.09% | $13.0M | 64 5-pillar |
| GCTK GlucoTrack, Inc. | $1.21 | -14.18% | — |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are MCDA's Key Strengths?
Niche market focus on home medical testing and mobile hospital units.
- Diverse product portfolio including human and pet test kits.
- Potential for recurring revenue through test kit refills and mobile unit services.
- Established brand recognition in specific geographic areas.
What Are MCDA's Weaknesses?
Limited market capitalization and financial resources.
- Dependence on regulatory approvals for test kit commercialization.
- High competition from established healthcare companies.
- OTC market listing increases investment risk.
What Are the Key Risks for MCDA?
Stringent regulatory requirements and compliance costs impacting profitability.
- Rapid technological advancements and product obsolescence reducing market competitiveness.
- Economic downturns impacting healthcare spending and consumer demand.
- High competition from established healthcare companies with greater resources.
- OTC market listing increases investment risk due to limited financial disclosure and liquidity.
What Are MCDA's Competitive Advantages?
- Specialized product offerings in home medical testing and mobile medical units.
- Proprietary technology in mobile unit communication systems.
- Established presence in the niche market of pet home medical testing.
- First-mover advantage in certain geographic regions.
What Does MCDA Do?
Founded in 2000 and based in Pompano Beach, Florida, KMA Holding, Inc. operates in the healthcare sector, specifically within the medical instruments and supplies industry. Originally named Macada Holding, Inc., the company rebranded to KMA Holding, Inc. in March 2011. KMA Holding focuses on the manufacturing and distribution of human and pet home medical test kits, along with emergency response mobile hospital units. These kits facilitate the detection of various illnesses, including cancer, through the analysis of blood, saliva, urine, hair, and other substances. The company’s product line includes home screening medical detection test kits for drugs of abuse, sexually transmitted diseases, infectious diseases, tumor markers, and fertility. KMA Holding also offers pet home medical test kits for conditions like cancer, diabetes, and Lyme disease. Furthermore, the company provides emergency medical response mobile hospital units, designed to offer temporary emergency life support, medical and pharmaceutical products and services, and communication via secured wireless technology. KMA Holding aims to provide accessible and rapid diagnostic solutions for both humans and pets, along with mobile medical infrastructure for emergency situations.
What Products and Services Does MCDA Offer?
- Manufactures home medical test kits for humans.
- Manufactures home medical test kits for pets.
- Provides home screening medical detection test kits for various conditions.
- Offers emergency medical response mobile hospital units.
- Provides temporary emergency life support through mobile units.
- Offers medical and pharmaceutical products and services.
- Provides communication via secured wireless technology within its mobile units.
How Does MCDA Make Money?
- Manufacturing and selling home medical test kits directly to consumers.
- Providing emergency medical response mobile hospital units to healthcare providers and government agencies.
- Generating revenue through the sale of medical and pharmaceutical products and services within the mobile units.
What Industry Does MCDA Operate In?
KMA Holding, Inc. operates within the medical instruments and supplies industry, a segment experiencing growth due to increasing demand for home healthcare solutions and point-of-care diagnostics. The market is characterized by technological advancements, stringent regulatory requirements, and intense competition. Companies like BRSYF (Bristol Myers Squibb), CYBQY (CyboSoft General Cybernetics), EVGRF (Evergreen Sustainable Development), GNFTF (Genenta Science), and MFCSF (Medifocus) represent the competitive landscape. KMA Holding's focus on home testing kits and mobile hospital units positions it within a niche market, requiring effective marketing and distribution strategies to capture market share.
Who Are MCDA's Key Customers?
- Individual consumers seeking convenient home medical testing.
- Pet owners looking for early detection of diseases in their pets.
- Hospitals and clinics requiring mobile emergency medical facilities.
- Government agencies needing mobile medical support during emergencies.
Research confidence
Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.
- ● Scoring coverage unknown
- ● No usable price
- ● No filing on record
- ● No analyst coverage
Company Profile
KMA Holding, Inc. operates in the Medical - Instruments & Supplies industry within the Healthcare sector. It is headquartered in Pompano Beach, US. The company is led by CEO Ronald Ritter. MCDA has traded publicly since 2010.
KMA Holding, Inc. (MCDA) Valuation Context
Valued at $4.24M, MCDA is classified as a micro-cap stock.
MCDA Financials
MCDA Latest News
No recent news available for MCDA.
MCDA Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for MCDA.
Price Targets
Wall Street price target analysis for MCDA.
MCDA MoonshotScore
MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for MCDA; grades run from A+ (80-100) to F (below 30).
Leadership: Ronald Ritter
CEO
Ronald Ritter serves as the Chief Executive Officer of KMA Holding, Inc. His background includes experience in the healthcare and medical device industries. Ritter has held various leadership positions, focusing on strategic planning, product development, and market expansion. His expertise lies in identifying market opportunities and driving business growth through innovative solutions. Ritter's leadership aims to position KMA Holding as a key player in the home medical testing and mobile healthcare sectors.
Track Record: Under Ronald Ritter's leadership, KMA Holding, Inc. has focused on expanding its product line of home medical test kits and mobile hospital units. Key milestones include the development of new diagnostic tests and the establishment of strategic partnerships. Ritter has overseen efforts to enhance the company's market presence and improve operational efficiency. However, specific financial achievements and performance metrics under his tenure are not readily available.
MCDA OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that KMA Holding, Inc. may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB. Companies in this tier often have limited financial disclosure and may be subject to greater regulatory scrutiny. Unlike companies listed on major exchanges like the NYSE or NASDAQ, OTC Other companies face fewer listing requirements, resulting in increased risk and potential for speculative trading. Investors should exercise caution and conduct thorough due diligence before investing in OTC Other stocks.
- OTC Tier: OTC Other
- Limited Financial Disclosure: Lack of comprehensive financial reporting increases the difficulty of assessing the company's financial health.
- Low Liquidity: Minimal trading volume and wide bid-ask spreads can result in price volatility and difficulty in executing trades.
- Shell Risk: The detection of shell risk indicates potential issues with the company's structure and operations.
- Regulatory Scrutiny: OTC Other companies are subject to greater regulatory scrutiny due to their lower listing standards.
- Speculative Trading: Increased potential for speculative trading and market manipulation.
- Verify the company's legal registration and compliance status.
- Review available financial statements and assess the company's financial health.
- Investigate the background and experience of the company's management team.
- Evaluate the company's business model and competitive landscape.
- Assess the company's regulatory risks and compliance requirements.
- Monitor trading volume and price volatility.
- Consult with a qualified financial advisor.
- Established history of operations since 2000.
- Focus on manufacturing and distributing tangible products (home medical test kits and mobile hospital units).
- Presence in the healthcare sector, addressing a real market need.
- CEO with experience in the healthcare and medical device industries.
- Company headquarters located in Pompano Beach, Florida.
KMA Holding, Inc. Healthcare Stock: Key Questions Answered
What does KMA Holding, Inc. do?
KMA Holding, Inc. manufactures and distributes home medical test kits for both humans and pets, along with emergency response mobile hospital units.
What do analysts say about MCDA stock?
As of 2026-03-16, formal analyst ratings for KMA Holding, Inc. (MCDA) are not widely available due to its OTC market listing and limited coverage.
What are the main risks for MCDA?
The main risks for KMA Holding, Inc. include its OTC market listing, which entails limited financial disclosure and liquidity challenges. The detection of shell risk raises concerns about the company's structure and operations.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
MoonshotScore is not published for this security.
Data provided for informational purposes only.
- Limited financial data available due to OTC listing.